3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Lung Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Thoracic Diseases
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Lymphoma
1
Liver Neoplasms
1
Leukemia
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
pembrolizumab
24
Nivolumab
19
atezolizumab
9
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Cyclophosphamide
7
durvalumab
5
Ipilimumab
5
fludarabine
4
Trastuzumab
4
cemiplimab
3
cabozantinib
3
avelumab
3
Sunitinib
3
Biopsy
3
ulixertinib
2
toripalimab
2
tislelizumab
2
spartalizumab
2
sargramostim
2
relatlimab
2
palbociclib
2
lenvatinib
2
epacadostat
2
enzalutamide
2
cyclopropapyrroloindole
2
copanlisib
2
budigalimab
2
aldesleukin
2
X-Rays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Tissue Banks
×
Thoracic
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled